Hologic Stock (NASDAQ:HOLX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$78.57

52W Range

$67.59 - $84.67

50D Avg

$80.56

200D Avg

$77.56

Market Cap

$18.13B

Avg Vol (3M)

$1.44M

Beta

0.99

Div Yield

-

HOLX Company Profile


Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

6,990

IPO Date

Mar 01, 1990

Website

HOLX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 23Sep 22Sep 21
Capital Equipment, Components and Software$740.50M$587.60M$769.10M
Service$750.50M$652.40M$598.10M
Other Type of Revenue$20.00M$19.20M$66.90M
Consumables$2.54B$3.60B$4.20B

Fiscal year ends in Sep 23 | Currency in USD

HOLX Financial Summary


Sep 23Sep 22Sep 21
Revenue$4.03B$4.86B$5.63B
Operating Income$668.40M$1.64B$2.48B
Net Income$456.00M$1.30B$1.87B
EBITDA$1.20B$2.10B$2.89B
Basic EPS$1.85$5.18$7.28
Diluted EPS$1.83$5.13$7.21

Fiscal year ends in Sep 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Nov 04, 24 | 7:26 PM
Q3 24Jul 29, 24 | 8:40 PM
Q2 24May 02, 24 | 12:00 AM

Peer Comparison


TickerCompany
MMSIMerit Medical Systems, Inc.
COOThe Cooper Companies, Inc.
BDXBecton, Dickinson and Company
WSTWest Pharmaceutical Services, Inc.
ALCAlcon Inc.
RMDResMed Inc.
NVSTEnvista Holdings Corporation
ANGOAngioDynamics, Inc.
HAEHaemonetics Corporation
ICUIICU Medical, Inc.
ATRAptarGroup, Inc.
TFXTeleflex Incorporated